These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35478141)

  • 21. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma.
    Thomas RM; Truty MJ; Kim M; Kang Y; Zhang R; Chatterjee D; Katz MH; Fleming JB
    Ann Surg Oncol; 2015; 22(6):1884-92. PubMed ID: 25404477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding primary tumor.
    Wen S; Lin X; Luo W; Pan Y; Liao F; Wang Z; Zhan B; Feng J; Huang H
    BMC Cancer; 2024 Apr; 24(1):485. PubMed ID: 38632504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation.
    Xiao Q; Zhou D; Rucki AA; Williams J; Zhou J; Mo G; Murphy A; Fujiwara K; Kleponis J; Salman B; Wolfgang CL; Anders RA; Zheng S; Jaffee EM; Zheng L
    Cancer Res; 2016 Sep; 76(18):5395-404. PubMed ID: 27496707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites.
    Allaway RJ; Fischer DA; de Abreu FB; Gardner TB; Gordon SR; Barth RJ; Colacchio TA; Wood M; Kacsoh BZ; Bouley SJ; Cui J; Hamilton J; Choi JA; Lange JT; Peterson JD; Padmanabhan V; Tomlinson CR; Tsongalis GJ; Suriawinata AA; Greene CS; Sanchez Y; Smith KD
    Oncotarget; 2016 Mar; 7(13):17087-102. PubMed ID: 26934555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model.
    Sugisawa N; Miyake K; Higuchi T; Oshiro H; Park JH; Kawaguchi K; Bouvet M; Unno M; Hoffman RM
    Anticancer Res; 2022 Feb; 42(2):739-743. PubMed ID: 35093872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An orthotopic model of ductal adenocarcinoma of the pancreas in severe combined immunodeficient mice representing all steps of the metastatic cascade.
    Alves F; Contag S; Missbach M; Kaspareit J; Nebendahl K; Borchers U; Heidrich B; Streich R; Hiddemann W
    Pancreas; 2001 Oct; 23(3):227-35. PubMed ID: 11590317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
    Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
    Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
    Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
    Okada S; Vaeteewoottacharn K; Kariya R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.
    Zeleniak AE; Huang W; Brinkman MK; Fishel ML; Hill R
    Oncotarget; 2017 Mar; 8(10):16473-16487. PubMed ID: 28146435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
    Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
    Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and application of patient-derived xenograft models in pancreatic cancer research.
    Wang CF; Shi XJ
    Chin Med J (Engl); 2019 Nov; 132(22):2729-2736. PubMed ID: 31725451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenografts.
    Hoover M; Adamian Y; Brown M; Maawy A; Chang A; Lee J; Gharibi A; Katz MH; Fleming J; Hoffman RM; Bouvet M; Doebler R; Kelber JA
    Oncotarget; 2017 Jan; 8(4):5885-5894. PubMed ID: 27602776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
    Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
    Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples.
    Choi SI; Jeon AR; Kim MK; Lee YS; Im JE; Koh JW; Han SS; Kong SY; Yoon KA; Koh YH; Lee JH; Lee WJ; Park SJ; Hong EK; Woo SM; Kim YH
    Front Oncol; 2019; 9():875. PubMed ID: 31572675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth.
    Li X; Kang Y; Roife D; Lee Y; Pratt M; Perez MR; Dai B; Koay EJ; Fleming JB
    Oncogene; 2017 Sep; 36(38):5432-5438. PubMed ID: 28534517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
    Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ
    Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review.
    Tanaka T; Nishie R; Ueda S; Miyamoto S; Hashida S; Konishi H; Terada S; Kogata Y; Sasaki H; Tsunetoh S; Taniguchi K; Komura K; Ohmichi M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
    Ene-Obong A; Clear AJ; Watt J; Wang J; Fatah R; Riches JC; Marshall JF; Chin-Aleong J; Chelala C; Gribben JG; Ramsay AG; Kocher HM
    Gastroenterology; 2013 Nov; 145(5):1121-32. PubMed ID: 23891972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.